Introduction to Medication-Assisted Treatment: A Comprehensive Approach to Recovery

Addiction is a chronic, relapsing disorder characterized by compulsive drug seeking, continued use despite harmful consequences, and long-lasting changes in the brain. It is a complex condition that often requires a multifaceted approach for effective treatment. One of the most promising and evidence-based methods for treating addiction is Medication-Assisted Treatment (MAT). This approach combines the use of medication with counseling and behavioral therapies to provide a “whole-patient” approach to the treatment of substance use disorders.

According to Dr. Abraham Wikler’s theory of opioid addiction, when a physical dependence is developed, a pharmacological need also develops, and it is through this “pharmacological need” that maintains an addiction when the initial euphoria that creates the physical dependence starts to wane.” The pharmacological need is appetitive. This means that gratification comes by getting more and more of the reinforcer, the opioid, and not “aversive.” Adverse refers to a negative reinforcer where gratification comes by getting less and less of the reinforcer (Spayde-Baker & Patek, 2023).

Medication-assisted treatment starts by treating the pharmacological need through the use of an FDA approved medication. Once the physiological need is removed or lessened, the recovering individual is better able to focus on rebuilding their life and addr4eessing other problems associated to the addiction.

The Principles of Medication-Assisted Treatment

The foundation of MAT lies in its holistic approach to treating addiction. The primary components include:

• Medication: Subjects caught in addiction can use drugs approved by the Food and Drug Administration (FDA) to normalize brain chemistry, block the euphoric effects of alcohol and opioids, relieve physiological cravings, and normalize body functions without the negative effects of the abused drug.
• Counseling: This includes one-on-one therapy, group therapy, and family therapy aimed at addressing the psychological aspects of addiction, helping patients to develop coping strategies, and addressing any co-occurring mental health conditions.
• Behavioral Therapies: Therapists and addiction counselors employ techniques such as cognitive-behavioral therapy (CBT), motivational interviewing (MI), and contingency management to change the patient’s behaviors and attitudes related to drug use, improve life skills, and support other treatments.

Medications Used in Medication-Assisted Treatment

Different medications are used in MAT depending on the substance being abused.

Opioid Addiction

• Methadone: A long-acting opioid agonist that reduces opioid cravings and withdrawal symptoms. It is dispensed daily in specialized clinics (Spayde-Baker & Patek, 2023).
• Buprenorphine: A partial opioid agonist that can reduce cravings and withdrawal symptoms without producing the same high as other opioids. It can be prescribed by certified physicians and taken at home (Spayde-Baker & Patek, 2023; Mitchell, 2017).
• Naltrexone: An opioid antagonist that blocks the euphoric and sedative effects of opioids. It can be administered as a daily tablet or a monthly injection (Spayde-Baker & Patek, 2023).

Alcohol Addiction

• Disulfiram: Causes an adverse reaction when the individual consumes alcohol by interfering with the metabolism of alcohol, leading to unpleasant effects that deter drinking (Parsons, 2018)
• Acamprosate: Helps normalize brain activity disrupted by chronic alcohol exposure and reduces cravings and withdrawal symptoms (Parsons, 2018).
• Naltrexone: Also used for alcohol use disorder, it reduces the reinforcing effects of alcohol, making drinking less pleasurable (Parsons, 2018).

Tobacco Addiction

• Nicotine Replacement Therapies (NRTs): Such as patches, gums, lozenges, nasal sprays, and inhalers, provide a low dose of nicotine to reduce withdrawal symptoms and cravings (Wilken et al., 2005).
• Varenicline: Reduces both cravings for and pleasurable effects of nicotine (Wilken et al., 2005).
• Bupropion: An antidepressant that also reduces cravings and withdrawal symptoms (Wilken et al., 2005).

The Benefits of MAT

MAT has been shown to be highly effective in treating substance use disorders. Some of the key benefits include:

• Reduction in Overdose Deaths: MAT reduces the risk of fatal overdose, especially with opioid addiction, by stabilizing the brain’s chemistry and reducing cravings.
• Improved Retention in Treatment: Patients receiving MAT are more likely to stay in treatment for longer periods, which is associated with better outcomes.
• Better Social Functioning: MAT can improve patients’ ability to maintain employment, stable housing, and positive relationships.
• Lower Risk of Infectious Diseases: By reducing risky behaviors associated with drug use, MAT lowers the risk of HIV, hepatitis, and other infectious diseases.

Challenges and Misconceptions

Despite its proven effectiveness, MAT faces several challenges and misconceptions.

Stigma

There is a significant stigma associated with MAT, both within the medical community and the general public. Some view the use of medications as simply substituting one addiction for another. This misconception fails to recognize the evidence-based nature of MAT and its role in comprehensive addiction treatment.

We have come along way in our approach to addiction. While helping an adult son fighting with Opioid use disorder, I saw that the bias continues in full-force. While picking-up medication, he was almost always dismissed until the pharmacists helped the ‘real’ customers. We cling to the belief that addiction is a simple choice, ignoring all the research. Understandably, a person on addiction is often unstable and sometimes dangerous. However, addiction is much more complex than a simple choice.

Louise Kaplan, Ph.D., instructs treatment counselors to “practice the science, not an ideology.” Language matters.

Kaplan advises:

“Instead of thinking of patients as ‘junkies,’ ‘addicts,’ or ‘druggies,’ think of patients as people with SUDs. Rather than thinking of someone’s urine drug test as being ‘dirty’ or ‘clean,’ substitute that phrasing with ‘positive’ or ‘negative.’ Instead of thinking of someone as being ‘clean and sober,’ substitute that phrase with ‘a person in recovery.’ Avoid referring to a person as a methadone patient” (Kaplan, 2019).

Access and Availability

Access to MAT can be limited by regulatory barriers, lack of trained providers, and insufficient funding. Expanding access requires policy changes, increased funding, and training for healthcare providers.

Individualized Treatment

MAT is not a one-size-fits-all solution. It requires careful assessment and individualized treatment plans to address the unique needs of each patient. This includes considering the type of substance used, the presence of co-occurring disorders, and the patient’s personal history and preferences.

Integrative Therapy

Addiction takes over a person’s life. It becomes the underlying foundation of everything they do. While MAT may break the chain of physical need for an addictive chemical, it does not dissolve all the behavioral chains associated with periods of addiction. The person recovering from addiction must have a scaffolding of support in many ways as they reintegrate into society.

Mary Addenbrooke wrote:

“After stopping, anyone who has been addicted is extremely vulnerable. The addiction itself has taken a toll both physically and psychologically. They have forgotten how to deal with everyday life without the drug and they have to start learning how to cope. A radical turnaround starts with simple steps in mastering life skills, as well as filling the gap left by the absence of drug-determined activities” (Addenbrooke, 2011, p. 96).

A major obstacle of MAT is that once a person begins medication-assisted treatment, they feel fine, as if the whole world of addiction is behind them. However, much of their life, including cognitions, are fragmented. The cost of addiction is seen across many life domains. Typically, finances, relationships, employment, and hobbies are all a mess. Medication does not solve these issues. The medication helps put a person in a better place so they can resolve these issues.

Environments Likely to Produce Addiction

Sometimes addiction is the end result of a misfortunate chain of events. More often, however, it is the likely endpoint of a complex interaction between personality, disorders included, and environments likely to accompany those traits. Basically, if a person has high impulsivity, making decision on shortsighted goals, the likelihood that they will have similar minded friends is much higher.

Jim Orford, renown in the field of addiction, wrote that consumption habits are not “simply discrete, isolated behavioural acts.” Consumption habits are the consequence of a whole sequence of events and chains of actions which led up to consumption. The consumption is then accompanied by “a host of cues, prompts and encouragements” (Orford, 2013, p. 54).

Sandra Scarr and Kathleen McCartney posit that:

“Development is indeed the result of nature and nurture but that genes drive experience. Genes are components in a system that organizes the organism to experience its world. The major problem with attempts to separate environmental from genetic effects and their combinations is that people evoke and select their own environments to a great extent” (Scarr & McCartney, 1983).

Basically, unconscious forces related to our genetics and early life experiences contribute to the formation of an environment. In the context of addiction, this means these forces strongly contribute to forming and choosing environments that support addiction.

A medication doesn’t solve these complex hidden forces. A medication just removes one of the elements.

See Integrative Therapy for more on this topic

Relapse

Usually there is a point in treatment, either determined by the individual or the program where the medication is reduced. These moments are critical junctions in recovery. Kyra Bobinet, MD, warns that even if you’ve been on your new path for a while, “relapse into old behavior is not just a possibility—it’s a probability” (Bobinet, 2016). Carlos DiClemente, famous for his theory on stages of change, wrote that patterns of behavior are “not usually created, modified, or stopped in a single moment in time or with a single flick of a switch. Changes are manifestations of numerous “steps or segments” that preceded the behavioral change (DiClemente, 2005, p. 25).

In one study, the researchers identified three other factors in addition to medication that proved essential for preventing relapse. A research study involving 100 heroin addicts treated in hospitals identified four key factors that contribute to remaining relapse-free for a year or longer. These factors include mandatory supervision, such as parole or employment, reliance on substitute medications like methadone, the establishment of new and stable relationships, and participation in supportive group memberships like self-help organizations or Narcotics Anonymous (Donovan & Marlatt, 2005).

With the highly effective impact of medication on addiction, many programs emerged that treated the physical addition. However, many of these programs largely ignored or proved inadequate to treat the behavioral aspect. As a consequence, relapse continued at a high rate.

See Relapse Prevention for more on this topic

Associated Concepts

• Substance Use Disorder: This is a medical condition characterized by a persistent pattern of substance use that causes significant impairment or distress. This disorder involves the compulsive use of a substance, despite negative consequences.
• EMDR-DeTur Protocol: The EMDR-DeTur protocol, which stands for Eye Movement Desensitization and Reprocessing, is a therapeutic approach specifically adapted for treating addiction. It combines traditional EMDR techniques with strategies tailored to address the underlying trauma and negative beliefs that often contribute to addictive behaviors.
• Stages of Change: This model, also known as the transtheoretical model, describes a series of stages that individuals may go through when making a significant behavior change.
• Locus of Control: This concept refers to the degree to which people believe they have control over the outcomes of events in their lives. Individuals with a high internal locus of control often have higher self-efficacy because they believe their actions directly impact their success.
• Habit Formation: This concept is a core aspect of behaviorism, with key elements including stimulus-response bonds, reinforcement, contextual cues, habit loops, impulsive vs. reflective processes, and behavioral automaticity. Understanding these concepts helps individuals intentionally shape their behaviors and cultivate lasting changes aligned with their goals and well-being.
• High-Risk Situations: In recovery, certain elements create high-risk environmental cues for relapse. Identifying and protecting against high risk situations is essential for successful recovery.
• Impulsivity: This is the tendency to act on a whim without considering the consequences of one’s actions. It involves a lack of reflection, planning, or foresight, often leading to hasty decisions. Impulsivity is commonly associated with difficulty in inhibiting an immediate response and can manifest in various behaviors, such as risk-taking, sensation-seeking, and difficulty in delaying gratification.

A Few Words by Psychology Fanatic

In the journey of recovery from addiction, Medication-Assisted Treatment (MAT) stands as a beacon of hope and resilience. By integrating evidence-based medications with therapeutic counseling and behavioral strategies, MAT not only addresses the physical aspects of substance use disorders but also nurtures the emotional and psychological well-being of individuals on their path to healing. This comprehensive approach acknowledges that recovery is not merely about abstaining from substances; it involves rebuilding lives, fostering connections, and rediscovering purpose in a world often overshadowed by stigma and misunderstanding.

As we continue to navigate the complexities of addiction treatment amidst an ongoing crisis, it is imperative that we advocate for broader access to MAT and cultivate a culture that embraces compassion over judgment. Each person’s experience with addiction is unique, shaped by their circumstances, challenges, and strengths. By supporting innovative treatment solutions like MAT while promoting education around its benefits, we can empower individuals to reclaim their lives. Together, let us champion understanding and acceptance as vital components in transforming our society’s response to addiction—ensuring that every individual has the opportunity for lasting recovery and a brighter future ahead.

Last Update: October 5, 2025

References:

Addenbrooke, Mary (2011). Survivors of Addiction: Narratives of Recovery. Routledge; 1 edition. ISBN: 9781583917251; APA Record: 2011-15496-000
(Return to Main Text)

Bobinet, Kyra (2016). How to Stop Falling Back Into Old Habits. Experience Life. Published: 3-23-2016; Accessed: 8-21-2024. Website: https://experiencelife.lifetime.life/article/relapse-recovery/
(Return to Main Text)

DiClemente, Carlos C. (2005). Addiction and Change, Second Edition: How Addictions Develop and Addicted People Recover. The Guilford Press; Second edition. ISBN-10: 146253323X; APA Record: 2017-40890-000
(Return to Main Text)

Donovan, Dennis M.; Marlatt, G. Alan (2005). Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors. The Guilford Press. ISBN: 9781593856410; APA Record: 2005-08721-000
(Return to Main Text)

Kaplan, Louis (2019). Medication-assisted treatment for opioid use disorder. The Nurse Practitioner, 44(3). DOI: 10.1097/01.NPR.0000550252.04526.79
(Return to Main Text)

Mitchell, Tracey Helton (2017). The Big Fix: Hope After Heroin. Seal Press; Reprint edition. ISBN-13: 9781580056045
(Return to Main Text)

Orford, Jim (2013). Power, Powerlessness and Addiction. Cambridge University Press. ISBN: 9781107610095; DOI: 10.1017/CBO9781139540971
(Return to Main Text)

Parsons, Graham (2018). Treatment options for alcohol use disorders. Prescriber, 29(12), 13-18. DOI: 10.1002/psb.1723
(Return to Main Text)

Scarr, Sandra; McCartney, Kathleen (1983). How people make their own environments: a theory of genotype-environment effects. Child Development, 54, 424 435. Website: https://psycnet.apa.org/record/1983-25048-001
(Return to Main Text)

Spayde-Baker, Amanda; Patek, Jennifer (2023). A Comparison of Medication-Assisted Treatment Options for Opioid Addiction. Journal of Addictions Nursing, 34(4), E189-E194. DOI: 10.1097/JAN.0000000000000392
(Return to Main Text)

Wilken, L.; Corbridge, S.; Simpson, S. (2005). Smoking Cessation—Part III: Pharmacotherapy of Smoking Cessation. AAOHN journal : Official journal of the American Association of Occupational Health Nurses, 53(8), 340-344. DOI: 10.1177/216507990505300805
(Return to Main Text)